mofezolac has been researched along with Intestinal Diseases in 1 studies
mofezolac: Cyclooxygenase 1 inhibitor; structure in first source; RN from Toxlit
Intestinal Diseases: Pathological processes in any segment of the INTESTINE from DUODENUM to RECTUM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ohkubo, M | 1 |
| Katsuta, T | 1 |
| Masunaga, A | 1 |
| Araki, E | 1 |
| Ichiki, T | 1 |
| Kodama, R | 1 |
| Yamashita, K | 1 |
1 other study available for mofezolac and Intestinal Diseases
| Article | Year |
|---|---|
[Fifty two-week chronic oral toxicity study of mofezolac (N-22) in beagle dogs].
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Dogs; Female; Intestinal Dis | 1990 |